$DOV

Morgan Stanley Adjusts Price Target on Dover to $215 From $230, Keeps Equalweight Rating

Morgan Stanley adjusted its price target on Dover Corp to $215 from $230 and kept an Equalweight rating, according to the brokerage. The article provides Dover’s business segment mix and geographic revenue distribution but no other financial figures.

Original reporting
Published Aug 10, 2026, 10:05 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 10:52 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$DOV
Neutral
low confidence
Mentioned
$DOV
Relevance
4/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$DOVNeutralLow
01

Why it matters

A price-target reduction from $230 to $215 can influence short-term sentiment, but the Equalweight rating being maintained suggests the analyst still expects roughly market-like performance.

02

Market read

Traders may monitor whether this target cut is part of a broader estimate reset cycle for industrials, but the article body provides no additional catalysts.

03

What to watch

Without the analyst’s stated drivers (estimates, margins, end-market demand, or valuation comps), it is unclear whether the target cut reflects fundamentals or just multiple compression.

Relevance 4/10Novelty 2/10Timing: analyst note dated 2026-08-10

Background

The article frames Dover as a diversified industrial with multiple product families and geographic sales mix, but does not provide new company-specific operating updates.

Company-level read

Ticker impact

$DOVNeutralLow confidence
Context

Morgan Stanley adjusted Dover’s price target to $215 from $230 while keeping an Equalweight rating, signaling a valuation view change.

Expected impact

Likely limited near-term impact unless traders treat the target cut as a broader downgrade signal.

Evidence & confidence

The provided body is largely generic and does not include the specific rationale behind the target change, limiting confidence in magnitude and direction.

Market effects

Minimal, since the article is a single-name analyst target adjustment with no sector-wide catalyst described.

None indicated.

None indicated.

Counterpoint

The unchanged Equalweight rating could mean the target cut is incremental and not a fundamental deterioration call, so the stock may not need to reprice much.

Key entities

  • Dover Corporation

    Subject of the analyst price-target adjustment referenced in the title.

  • Morgan Stanley

    Issuer of the price target change and rating maintenance.

Related articles

$DOVMed

OPW acquires cryogenic expertise

Dover Corp. (DOV) agreed to acquire Leistung Engineering, an India-based cryogenic valve manufacturer, for its OPW Fluid Transfer Solutions segment. Leistung has shown double-digit growth and will serve as a strategic hub for Dover in India's growing LNG market. The deal is expected to close in Q4, with terms undisclosed. Dover reported $8B in annual revenue.

$DOVMedAI 8/10

Dover to Acquire Leistung, Expand Manufacturing Footprint and Cryogenic Offerings

Dover Corporation (NYSE: DOV) will acquire Leistung Engineering Pvt. Ltd., a cryogenic valve manufacturer, to expand its Clean Energy & Fueling segment. Leistung's Indian facility will serve as a strategic manufacturing hub. The deal is expected to close in Q4, with terms undisclosed. Dover reported $8B in annual revenue. The acquisition aims to boost Dover's presence in the Indian market and global cryogenic solutions.

$DOVMed

Dover To Acquire Cloeren And Expand Polymer Processing Portfolio

Dover (according to the company) signed an agreement to acquire Cloeren, a maker of extrusion T-dies and feedblocks for polymer and plastics processing. Terms were not disclosed. The deal is expected to close in Q3 2026, subject to conditions, and Cloeren will join Dover’s MAAG unit in the Pumps and Process Solutions segment. Dover has $8B+ annual revenue.

$DOVMedAI 8/10

Dover to Acquire Cloeren, a Leading Manufacturer of T-dies and Feedblocks

Dover Corporation (NYSE: DOV) said it signed a definitive agreement to acquire Cloeren Incorporated, adding extrusion T-dies and feedblocks to the MAAG business unit in Dover’s Pumps & Process Solutions segment. Cloeren will be based in Orange, Texas, with other sites in Texas, Wisconsin, and Austria. The deal is expected to close in Q3; terms were not disclosed.

$DOVMed

Wall Street Zen Downgrades Dover (NYSE:DOV) to Hold

Wall Street Zen downgraded Dover (NYSE:DOV) from buy to hold in a Saturday research note. Other analysts cited include Deutsche Bank (hold, $229 target), Seaport Research (buy, raised to $265), and Citigroup (buy). Dover shares opened at $202.45. In the latest quarter, Dover reported $2.74 EPS and $2.19B revenue, and set FY2026 EPS guidance of 10.55 to 10.75.